Literature DB >> 21819701

Expression of aquaglyceroporins in epithelial ovarian tumours and their clinical significance.

J H Yang1, C X Yan, X J Chen, Y S Zhu.   

Abstract

Protein levels of aquaglyceroporins AQP3, AQP7 and AQP9 were measured by immunohistochemistry and Western blotting in epithelial ovarian tumour tissue from 98 patients and in normal ovary tissue from 20 persons with uterine myoma. AQP3 and AQP9 proteins were detected immunohistochemically in the basolateral membranes of benign and borderline tumour cells and were found to be distributed throughout the plasma membranes of malignant tumour cells. AQP7 protein was localized in the plasma membranes of benign tumour cells but, in borderline and malignant tumour cells, it was selectively stained in the nuclear membrane. Western blotting showed significantly higher AQP7 and AQP9 protein expression in malignant and borderline tumours than in benign tumour and normal ovarian tissue. AQP9 expression level was positively and significantly correlated with tumour grade and histological type. It was concluded that a high level of aquaglyceroporin expression may be an important factor in ovarian carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21819701     DOI: 10.1177/147323001103900302

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  10 in total

1.  Different Prognostic Implications of Aquaporin-1 and Aquaporin-5 Expression among Different Histological Types of Ovarian Carcinoma.

Authors:  Kimiya Sato; Morikazu Miyamoto; Masashi Takano; Kenichi Furuya; Hitoshi Tsuda
Journal:  Pathol Oncol Res       Date:  2018-07-19       Impact factor: 3.201

2.  Expression of AQP6 and AQP8 in epithelial ovarian tumor.

Authors:  Jiong Ma; Chunxia Zhou; Jianhua Yang; Xiaoyan Ding; Yunshan Zhu; Xuejun Chen
Journal:  J Mol Histol       Date:  2016-01-16       Impact factor: 2.611

3.  A Systematic Characterization of Aquaporin-9 Expression in Human Normal and Pathological Tissues.

Authors:  Cecilia Lindskog; Anna Asplund; Anca Catrina; Søren Nielsen; Michael Rützler
Journal:  J Histochem Cytochem       Date:  2016-03-29       Impact factor: 2.479

Review 4.  Aquaporins as diagnostic and therapeutic targets in cancer: how far we are?

Authors:  Jian Wang; Li Feng; Zhitu Zhu; Minghuan Zheng; Diane Wang; Zhihong Chen; Hongzhi Sun
Journal:  J Transl Med       Date:  2015-03-21       Impact factor: 5.531

5.  Maternal Protein Restriction Modulates Angiogenesis and AQP9 Expression Leading to a Delay in Postnatal Epididymal Development in Rat.

Authors:  Talita de Mello Santos; Marilia Martins Cavariani; Dhrielly Natália Pereira; Bruno César Schimming; Luiz Gustavo de Almeida Chuffa; Raquel Fantin Domeniconi
Journal:  Cells       Date:  2019-09-17       Impact factor: 6.600

6.  Expression and Significance of AQP3 in Cutaneous Lesions.

Authors:  Dongfeng Niu; Yanhua Bai; Qian Yao; Wei Hou; Lixin Zhou; Xiaozheng Huang; Chen Zhao
Journal:  Anal Cell Pathol (Amst)       Date:  2021-10-26       Impact factor: 2.916

Review 7.  Aquaglyceroporin Modulators as Emergent Pharmacological Molecules for Human Diseases.

Authors:  Catarina Pimpão; Darren Wragg; Inês V da Silva; Angela Casini; Graça Soveral
Journal:  Front Mol Biosci       Date:  2022-02-03

Review 8.  Clinical value and molecular mechanism of AQGPs in different tumors.

Authors:  Rui Wang; Xuejian Wang; Jun Zhao; Jiacheng Jin; Weiwei Fan; Xinqing Zhu; Qiwei Chen; Baochang Zhang; Lan Lan; Kexin Qu; Liang Zhu; Jianbo Wang
Journal:  Med Oncol       Date:  2022-08-16       Impact factor: 3.738

9.  Effect of AQP9 Expression in Androgen-Independent Prostate Cancer Cell PC3.

Authors:  Qiwei Chen; Liang Zhu; Bo Zheng; Jinliang Wang; Xishuang Song; Wei Zheng; Lina Wang; Deyong Yang; Jianbo Wang
Journal:  Int J Mol Sci       Date:  2016-05-14       Impact factor: 5.923

10.  Prognostic values of aquaporins mRNA expression in human ovarian cancer.

Authors:  Mandika Chetry; Saisai Li; Hailing Liu; Xiaoli Hu; Xueqiong Zhu
Journal:  Biosci Rep       Date:  2018-04-27       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.